To ensure equitable healthcare outcomes across diverse populations, it is essential to involve patients from underrepresented communities in clinical research. In addition to reinforcing drug safety, expanding clinical trial diversity can help sponsors to stay on top of FDA and global health authority guidance, and to build patient trust in new treatment modalities.

A strategic alliance is an opportunity for multiple organizations to enhance drug development and commercialization by leveraging complementary strengths.

Download the SAP Concur Refresh eBook to explore the transformative benefits of a net-new SAP Concur site